Conversely, overexpressing ETS2 induced a striking, dose-dependent upregulation of the same pro-inflammatory pathways and induced a pathogenic state that closely resembled the macrophage phenotype seen in diseased tissue from conditions such as inflammatory bowel disease (IBD). Here, ETS2 is linked to inflammatory bowel disease.